ATNF fundamentals
180 Life Sciences Corp. earnings per share and revenue
Report periodQ3 2024
EPS estimate—
Revenue estimate—
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
−44.00
−33.00
−22.00
−11.00
0.00
0.00
8.00 M
16.00 M
24.00 M
32.00 M